Abstract
Expression of the apoptosis-promoting Fas gene is frequently reduced or lost during the development of colorectal carcinoma. However, loss of heterozygosity at the Fas locus or Fas gene rearrangements do not account for the loss of expression of Fas, raising the possibility that methylation of the Fas promoter may inhibit gene expression in colorectal carcinomas. We have examined the Fas promoter region CpG island for evidence of hypermethylation in colorectal tumours. Forty-seven specimens of colorectal adenoma and carcinoma, as well as six samples of normal colonic mucosa, were examined by Southern blotting for methylation at Hpa II and Cfo I sites in this region. No methylation was detected in any of the specimens, suggesting that hypermethylation is not primarily responsible for the loss of expression of the Fas gene during colorectal tumorigenesis. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahuja N, Li Q, Mohan AL, Baylin SB and Issa J-PJ (1998) Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58: 5489–5494
Baker SJ, Markowitz S, Fearon ER, Willson JKV and Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912–915
Baylin SB, Herman JG, Graff JR, Vertino PM and Issa J-P (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141–196
Behrmann I, Walczak H and Krammer PH (1994) Structure of the human APO-1 gene. Eur J Immunol 24: 3057–3062
Butler LM, Hewett PJ, Butler WJ and Cowled PA (1998) Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement. Br J Cancer 77: 1454–1459
Butler LM, Hewett PJ, Fitridge RA and Cowled PA (1999) Deregulation of apoptosis in colorectal cancer: theoretical and therapeutic implications. Aust NZ J Surg 69: 88–94
Chan H, Bartos DP and Owen-Schaub LB (1999) Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol Cell Biol 19: 2098–2108
Cheng J, Liu C, Koopman WJ and Mountz JD (1995) Characterization of human Fas gene. J Immunol 154: 1239–1245
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL and Paul CL (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827–1831
Goelz SE, Vogelstein B, Hamilton SR and Feinberg AP (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187–190
Hall PA, Coates PJ, Ansari B and Hopwood D (1994) Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 107: 3569–3577
Hiltunen MO, Alhonen L, Koistinaho J, Myöhänen S, Pääkkönen M, Marin S, Kosma V-M and Jänne J (1997) Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 70: 644–648
Iacopetta BJ, Harmon D, Spagnolo DV, House AK and Kay PH (1997) Hypermethylation of the Myf -3 gene in human colorectal cancer. Anticancer Res 17: 429–432
Issa J-P, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536–540
Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R (1997) Methylation of the hMLH1promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57: 808–811
Kuo MH and Allis CD (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20: 615–626
Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH and Möller P (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69: 415–429
Matsumoto Y, Hayakawa A, Tamada Y, Mori H and Ohashi M (1996) Upregulated expression of Fas antigen on cultured human keratinocytes with induction of apoptosis by cisplatin. Arch Dermatol Res 288: 267–269
Möller P, Koretz K, Leithauser F, Brüderlein S, Henne C, Quentmeier A and Krammer PH (1994) Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57: 371–377
Muller M, Strand S, Hug H, Heinemann E-M, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99: 403–413
Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang W-W, Kruzel E and Radinsky R (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15: 3032–3040
Reap EA, Roof K, Maynor K, Borrero M, Booker J and Cohen PL (1997) Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc Natl Acad Sci USA 94: 5750–5755
Reinke V and Lozano G (1997) The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. Oncogene 15: 1527–1534
Rudert F, Visser E, Forbes L, Lindridge E, Wang Y and Watson J (1995) Identification of a silencer, enhancer, and basal promoter region in the human CD95 (Fas/APO-1) gene. DNA Cell Biol 14: 931–937
Sheard MA, Vojtesek B, Janakova L, Kovarik J and Zaloudik J (1997) Up-regulation of Fas (CD95) in human p53wild-typecancer cells treated with ionizing radiation. Int J Cancer 73: 757–762
Silverman AL, Park J-G, Hamilton SR, Gazdar AF, Luk GD and Baylin SB (1989) Abnormal methylation of the calcitonin gene in human colonic neoplasms. Cancer Res 49: 3468–3473
Streeck RE (1980) Single-strand and double-strand cleavage at half-modified and fully modified recognition sites for the restriction nucleases Sau3A and Taq I. Gene 12: 267–275
Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M, Koh T, Ariyasu T, Tachi M, Kasuga M and Takahashi R (1995) Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 11: 1939–1946
Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301–304
Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y and White R (1989) Allelotype of colorectal carcinomas. Science 244: 207–211
Yonehara S, Ishii A and Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747–1756
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Butler, L., Dobrovic, A., Bianco, T. et al. Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma. Br J Cancer 82, 131–135 (2000). https://doi.org/10.1054/bjoc.1999.0889
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.0889
Keywords
This article is cited by
-
Down-Regulation of BAX Gene During Carcinogenesis and Acquisition of Resistance to 5-FU in Colorectal Cancer
Pathology & Oncology Research (2014)
-
Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer
British Journal of Cancer (2004)
-
Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma
Cell Death & Differentiation (2003)
-
Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns
British Journal of Cancer (2002)
-
Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer
Oncogene (2001)
